Menu Toggle site navigation

Breadcrumb

Título - Investigación y Evaluación Medicamentos

Doctoral Programme in Research and Evaluation of Drugs. Application of Pharmaceutical Technologies to the Development of Advanced Therapies

Nested Applications

Presentación - Investigación y Evaluación Medicamentos

The Doctoral Programme in Research and Evaluation of Drugs. The Application of Pharmaceutical Technology to the Development of Advanced Therapies comes directly under the framework of the pharmaceutical and biotechnology industry's R+D+i.

It encompasses lines of research in the field of pharmaceutical technology, gene and cell therapy, characterisation of biomaterials and particularly in the development of new controlled and continuous release drugs, peptides, proteins, nucleic acids and cells.

Projects are also developed that are associated with the biopharmaceutical, pharmacokinetic and pharmacotherapeutic evaluation of drugs, pharmaceutical care, and the regulation of biotechnological medicinal products.

We collaborate with different companies in the pharmaceutical and biotechnological field, as well as with a range of national and international health institutions, universities and research centres.

XSL Content

Ficha de Grado

Part-time studies

Duration: 5 - 8 cursos

Places available: 9

Approximate fees: 219 €/academic year

Ficha de Grado

Full-time studies

Duration: 3 - 5 cursos

Places available: 9

Approximate fees: 301 €/academic year

Contact

Academic queries: marian.solinis@ehu.eus

Administrative queries: aitziber.mojas@ehu.eus

Suggestions and requests

XSL Content

Research teams and research topics

Research teams and research topics
Research teamsResearch topics
Micro and Nano technologies. Biomaterials and cells. NanoBioCel
  • Biopharmaceutical evaluation, pharmacokinetics and pharmacotherapeutics of medicine. Pharmaceutical care
  • Development of micro and nanoparticle systems for drug formulation
  • Development of non-viral vectors for gene therapy
  • Development of pharmaceutical forms of modified release
  • Tissue engineering and cell therapy
Pharmacokinetics, nanotechnology and gene therapy. FarmaNanoGen
  • Biopharmaceutical evaluation, pharmacokinetics and pharmacotherapeutics of medicine. Pharmaceutical care
  • Development of micro and nanoparticle systems for drug formulation
  • Development of non-viral vectors for gene therapy
  • Development of pharmaceutical forms of modified release
  • Legal regulation of biotechnological medicines
  • Pharmacokinetic/pharmacodynamic analysis in anti-biotherapy